Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;109:2878-2884
Published online before print June 1, 2004, doi: 10.1161/01.CIR.0000129303.90488.29
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
109/23/2878    most recent
01.CIR.0000129303.90488.29v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lockhart, P. B.
Right arrow Articles by Weinrib, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lockhart, P. B.
Right arrow Articles by Weinrib, D. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*AMOXICILLIN
Medline Plus Health Information
*Dental Health
Related Collections
Right arrow Health policy and outcome research
Right arrow Infectious endocarditis
Right arrow Primary prevention
Right arrow Valvular heart disease
Right arrow Pediatric and congenital heart disease, including cardiovascular surgery
Right arrow Other Research

(Circulation. 2004;109:2878-2884.)
© 2004 American Heart Association, Inc.


Clinical Investigation and Reports

Impact of Amoxicillin Prophylaxis on the Incidence, Nature, and Duration of Bacteremia in Children After Intubation and Dental Procedures

Peter B. Lockhart, DDS; Michael T. Brennan, DDS, MHS; M. Louise Kent, RN; H. James Norton, PhD; David A. Weinrib, MD

From the Departments of Oral Medicine (P.B.L., M.T.B., M.L.K.), Internal Medicine (D.A.W.), and Biostatistics (H.J.N.), Carolinas Medical Center, Charlotte, NC.

Correspondence to Dr Peter B. Lockhart, Department of Oral Medicine, Carolinas Medical Center, 1000 Blythe Blvd, PO Box 32861, Charlotte, NC 28232-2861. E-mail Peter.Lockhart{at}carolinashealthcare.org

Received June 9, 2003; de novo received October 17, 2003; revision received February 10, 2004; accepted March 8, 2004.

Background— Controversy exists about the impact of prophylactic antibiotics on bacteremia after invasive dental procedures. The purpose of this double-blind, randomized, placebo-controlled study was to determine the impact of amoxicillin prophylaxis on the incidence, nature, and duration of bacteremia from nasotracheal intubation and dental procedures in children.

Methods and Results— Children were randomly assigned before surgery to the American Heart Association (AHA)–recommended dose of amoxicillin or to a placebo. Aerobic and anaerobic blood cultures were drawn at 8 specific time points after intubation, dental restorative and cleaning procedures, and before, during, and after dental extraction(s), to include blood drawings up to 45 minutes after the last extraction. Aerobic and anaerobic blood culture results were used to determine the incidence, nature, and duration of bacteremia from these procedures. For the 100 children enrolled (mean age, 3.5 years), the overall incidence of positive blood cultures, defined as at least 1 positive culture of the 8, was significantly higher in the placebo (84%) than the amoxicillin group (33%) (P<0.0001). Bacteremia occurrence rates after intubation and after dental restorations and cleaning were 18% and 20% in the placebo group and 4% and 6% in the amoxicillin group (P=0.05 and P=0.07, respectively). At 1.5 minutes after the initiation of dental extractions, bacteremia occurred in 76% of the placebo group versus 15% of the amoxicillin group (P<0.001). The majority of the 152 positive cultures and of the 29 different bacteria identified were Gram-positive cocci. Bacteremia persisted longer in the placebo group.

Conclusions— Bacteremia from these procedures occurs more often, from a wider variety of bacterial species, and for a longer duration after dental extractions than previously reported in any age group. Amoxicillin has a significant impact on the incidence, nature, and duration of bacteremia after nasal intubation, dental restorative and cleaning procedures, and dental extractions.


Key Words: endocardium • cardiovascular diseases • anesthesia • infection • trials




This article has been cited by other articles:


Home page
J Bone Joint Surg BrHome page
I. Uckay, D. Pittet, L. Bernard, D. Lew, A. Perrier, and R. Peter
Antibiotic prophylaxis before invasive dental procedures in patients with arthroplasties of the hip and knee
J Bone Joint Surg Br, July 1, 2008; 90-B(7): 833 - 838.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. B. Lockhart, M. T. Brennan, H. C. Sasser, P. C. Fox, B. J. Paster, and F. K. Bahrani-Mougeot
Bacteremia Associated With Toothbrushing and Dental Extraction
Circulation, June 17, 2008; 117(24): 3118 - 3125.
[Abstract] [Full Text] [PDF]


Home page
Journal of the American Dental AssociationHome page
W. Wilson, K. A. Taubert, M. Gewitz, P. B. Lockhart, L. M. Baddour, M. Levison, A. Bolger, C. H. Cabell, M. Takahashi, R. S. Baltimore, et al.
Prevention of infective endocarditis: Guidelines from the American Heart Association: A guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group
J Am Dent Assoc, January 1, 2008; 139(suppl_1): 3S - 24S.
[Abstract] [Full Text] [PDF]


Home page
J. Dent. Res.Home page
I. T. Carmona, P. Diz Dios, and C. Scully
Efficacy of Antibiotic Prophylactic Regimens for the Prevention of Bacterial Endocarditis of Oral Origin
J. Dent. Res., December 1, 2007; 86(12): 1142 - 1159.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. Wilson, K. A. Taubert, M. Gewitz, P. B. Lockhart, L. M. Baddour, M. Levison, A. Bolger, C. H. Cabell, M. Takahashi, R. S. Baltimore, et al.
Prevention of Infective Endocarditis: Guidelines From the American Heart Association: A Guideline From the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group
Circulation, October 9, 2007; 116(15): 1736 - 1754.
[Abstract] [Full Text] [PDF]


Home page
Journal of the American Dental AssociationHome page
W. Wilson, K. A. Taubert, M. Gewitz, P. B. Lockhart, L. M. Baddour, M. Levison, A. Bolger, C. H. Cabell, M. Takahashi, R. S. Baltimore, et al.
Prevention of infective endocarditis: Guidelines from the American Heart Association: A guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group
J Am Dent Assoc, June 1, 2007; 138(6): 739 - 760.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
T. B. Seto
The Case for Infectious Endocarditis Prophylaxis: Time to Move Forward
Arch Intern Med, February 26, 2007; 167(4): 327 - 330.
[Full Text] [PDF]


Home page
HeartHome page
S Di Filippo, F Delahaye, B Semiond, M Celard, R Henaine, J Ninet, F Sassolas, and A Bozio
Current patterns of infective endocarditis in congenital heart disease
Heart, October 1, 2006; 92(10): 1490 - 1495.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
P. Diz Dios, I. Tomas Carmona, J. Limeres Posse, J. Medina Henriquez, J. Fernandez Feijoo, and M. Alvarez Fernandez
Comparative Efficacies of Amoxicillin, Clindamycin, and Moxifloxacin in Prevention of Bacteremia following Dental Extractions.
Antimicrob. Agents Chemother., September 1, 2006; 50(9): 2996 - 3002.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. H. Rahimtoola
The year in valvular heart disease
J. Am. Coll. Cardiol., January 4, 2005; 45(1): 111 - 122.
[Full Text] [PDF]


Home page
AAP Grand RoundsHome page
L. L. Barton and M. H. Rathore
Dental Procedure Bacteremia and Antibiotic Prophylaxis
AAP Grand Rounds, October 1, 2004; 12(4): 42 - 43.
[Full Text] [PDF]